Canada markets open in 7 hours 29 minutes

Benitec Biopharma Inc. (BNTC)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
7.90-0.55 (-6.51%)
At close: 04:00PM EDT
8.44 +0.54 (+6.84%)
After hours: 06:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 20.48M
Enterprise Value 529.23k
Trailing P/E 51.55
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)90.64
Price/Book (mrq)1.32
Enterprise Value/Revenue 8.68
Enterprise Value/EBITDA -0.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.02
52-Week Change 3106.54%
S&P500 52-Week Change 323.57%
52 Week High 39.01
52 Week Low 31.86
50-Day Moving Average 35.47
200-Day Moving Average 33.71

Share Statistics

Avg Vol (3 month) 386.37k
Avg Vol (10 day) 3418.82k
Shares Outstanding 52.59M
Implied Shares Outstanding 68.34M
Float 81.37M
% Held by Insiders 110.42%
% Held by Institutions 145.05%
Shares Short (Apr 15, 2024) 412.22k
Short Ratio (Apr 15, 2024) 40.67
Short % of Float (Apr 15, 2024) 40.63%
Short % of Shares Outstanding (Apr 15, 2024) 40.47%
Shares Short (prior month Mar 15, 2024) 45.13k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 18, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:17
Last Split Date 3Jul 26, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-35,560.66%

Management Effectiveness

Return on Assets (ttm)-81.53%
Return on Equity (ttm)-178.30%

Income Statement

Revenue (ttm)61k
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.6M
Net Income Avi to Common (ttm)-21.81M
Diluted EPS (ttm)-236.13
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)20.37M
Total Cash Per Share (mrq)7.86
Total Debt (mrq)423k
Total Debt/Equity (mrq)2.73%
Current Ratio (mrq)3.62
Book Value Per Share (mrq)5.97

Cash Flow Statement

Operating Cash Flow (ttm)-18.07M
Levered Free Cash Flow (ttm)-9.6M